Prophylactic corticosteroid to prevent pain flare in bone metastases treated by radiotherapy
Abstract
BACKGROUND: The aim of this study was to evaluate the effectiveness of prophylactic corticosteroids to prevent pain flare (PF) in bone metastases treated with radiotherapy performing a meta-analysis of randomized clinical trials (RCT).
MATERIALS AND METHODS: RCTs were identified on Medline, Embase, the Cochrane Library, and the proceedings of annual meetings through June 2020. We followed the PRISMA and MOOSE guidelines. A meta-analysis was performed to assess if corticosteroids reduce the PF, pain progression, and the mean of days with PF compared with the placebo. A p-value < 0.05 was considered significant.
RESULTS: Three RCTs with a total of 713 patients treated were included. The corticosteroids reduced the occurrence of early PF 20.5% (51/248) versus 32% (80/250) placebo, OR= 0.55 (95% CI: 0.36–0.82, p = 0.002). The mean days of PF were reduced to 1.6 days (95% CI: 1.3–1.9, p = 0.0001). Prophylactic corticosteroids had more patients with no PF and no pain progression, OR = 1.63 (95% CI: 1.14–2.32, p = 0.007). No significant corticosteroids effect was observed for pain progression (p = ns) and late PF occurrence (p = ns).
CONCLUSION: Prophylactic corticosteroids reduced the incidence of early PF, the days with PF, resulting in a superior rate of patients with no PF and no pain progression, but with no significant benefit for reducing pain progression or late PF occurrence.
Keywords: bone metastasesradiotherapypain flarecorticosteroidsmeta-analysis
References
- Løhre ET, Thronæs M, Klepstad P. Breakthrough cancer pain in 2020. Curr Opin Support Palliat Care. 2020; 14(2): 94–99.
- Culleton S, Kwok S, Chow E. Radiotherapy for pain. Clin Oncol (R Coll Radiol). 2011; 23(6): 399–406.
- Chow R, Hoskin P, Schild SE, et al. Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis. Radiother Oncol. 2019; 141: 56–61.
- Goldfinch R, White N. An investigation into the incidence of pain flare in patients undergoing radiotherapy for symptomatic bone metastases. Radiography (Lond). 2018; 24(3): 192–195.
- McDonald R, Chow E, Rowbottom L, et al. Incidence of pain flare in radiation treatment of bone metastases: A literature review. J Bone Oncol. 2014; 3(3-4): 84–89.
- Gomez-Iturriaga A, Cacicedo J, Navarro A, et al. Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study. BMC Palliat Care. 2015; 14: 48.
- Hird A, Chow E, Zhang L, et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int J Radiat Oncol Biol Phys. 2009; 75(1): 193–197.
- Loi M, Klass ND, De Vries KC, et al. Pain flare, complexity and analgesia in bone oligometastases treated with stereotactic body radiation therapy. Eur J Cancer Care (Engl). 2018; 27(6): e12915.
- MacLeod K, Laird BJA, Carragher NO, et al. Predicting Response to Radiotherapy in Cancer-Induced Bone Pain: Cytokines as a Potential Biomarker? Clin Oncol (R Coll Radiol). 2020; 32(10): e203–e208.
- Lim FMY, Bobrowski A, Agarwal A, et al. Use of corticosteroids for pain control in cancer patients with bone metastases: a comprehensive literature review. Curr Opin Support Palliat Care. 2017; 11(2): 78–87.
- Niglas M, Raman S, Rodin D, et al. Should dexamethasone be standard in the prophylaxis of pain flare after palliative radiotherapy for bone metastases?-a debate. Ann Palliat Med. 2018; 7(2): 279–283.
- van der Linden YM, Westhoff PG, Stellato RK, et al. Dexamethasone for the Prevention of a Pain Flare After Palliative Radiation Therapy for Painful Bone Metastases: The Multicenter Double-Blind Placebo-Controlled 3-Armed Randomized Dutch DEXA Study. Int J Radiat Oncol Biol Phys. 2020; 108(3): 546–553.
- Yousef AAM, El-Mashad NM. Pre-emptive value of methylprednisolone intravenous infusion in patients with vertebral metastases. A double-blind randomized study. J Pain Symptom Manage. 2014; 48(5): 762–769.
- Chow E, Meyer RM, Ding K, et al. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol. 2015; 16(15): 1463–1472.
- Fagard RH, Staessen JA, Thijs L. Advantages and disadvantages of the meta-analysis approach. J Hypertens Suppl. 1996; 14(2): S9–12; discussion S13.
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339: b2700.